{"id":"W3136388199","doi":"10.1182/blood.2020008787","title":"Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Ixazomib; Medicine; Lenalidomide; Hazard ratio; Placebo; Internal medicine; Multiple myeloma; Adverse effect; Clinical endpoint; Surgery; Randomized controlled trial; Confidence interval; Carfilzomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001199395,0.0004255338,0.001399595,0.0002548156,0.0002551623,0.0006950742,0.0003772094,0.000653576,0.002005943],"category_scores_gemma":[0.000915291,0.0002621513,0.001077789,0.000308103,0.0005199133,0.0005164805,0.0003113182,0.001379311,0.0002276032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006533244,"about_ca_system_score_gemma":0.0006904234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007789388,"about_ca_topic_score_gemma":0.003293707,"domain_scores_codex":[0.9995639,0.0002349679,0.00003761793,0.00006373203,0.00004507776,0.00005469525],"domain_scores_gemma":[0.9995216,0.0001307619,0.0001318483,0.00002875856,0.00001379868,0.0001731405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7987338,0.00619276,0.009812376,0.001411983,0.001450311,0.0001351572,0.000127609,0.0007679511,0.009025256,0.0002310842,0.00159923,0.1705125],"study_design_scores_gemma":[0.6647709,0.2715446,0.05249259,0.0002802203,0.001884049,0.0003209416,0.0001251605,0.001210336,0.002013003,0.0004163494,0.004897816,0.00004401709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750299,0.02197776,0.0003078587,0.0007306874,0.0002177436,0.0004015325,0.0003224084,0.0000417915,0.0009703711],"genre_scores_gemma":[0.9924377,0.005388924,0.0003621067,0.0005201463,0.0001379701,0.0002528677,0.0003655043,0.000004525838,0.000530419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002005943,"threshold_uncertainty_score":0.006710529,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02112307628698407,"score_gpt":0.2706262419289036,"score_spread":0.2495031656419195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}